iwNHL 2019 | CAR-T for lymphoma: new targets, real world data & resistance

Barbara Savoldo, Catherine Bollard, David Maloney and Max Mamonkin

Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children’s National Health System, Washington, DC is joined by David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, Max Mamonkin, PhD, Baylor College of Medicine, Houston, TX, and Barbara Savoldo, MD, PhD, of UNC School of Medicine, Chapel Hill, NC, for a roundtable discussion at the 17th International Workshop on Non-Hodgkin Lymphoma, held in Boston, MA. CAR T-cell therapies for lymphoma are discussed, including the targeting of CD5, CD17, CD19, CD20 and CD30, resistance, and real world data.

Share this video